Press "Enter" to skip to content

New patent for Zogenix Inc drug FINTEPLA

0
Copyright © DrugPatentWatch. Originally published at New patent for Zogenix Inc drug FINTEPLA

Annual Drug Patent Expirations for FINTEPLA
Annual Drug Patent Expirations for FINTEPLA

Fintepla is a drug marketed by Zogenix Inc and is included in one NDA. It is available from one supplier. There are ten patents protecting this drug.

This drug has forty-six patent family members in twenty countries.

The generic ingredient in FINTEPLA is fenfluramine hydrochloride. One supplier is listed for this compound. Additional details are available on the fenfluramine hydrochloride profile page.

For more information on how DrugPatentWatch can help with your pharmaceutical business intelligence needs, contact admin@DrugPatentWatch.com or visit www.DrugPatentWatch.com

Make Better Decisions with DrugPatentWatch

Get the Daily Briefing or Try a trial

Copyright © DrugPatentWatch. Originally published at New patent for Zogenix Inc drug FINTEPLA
Online Certificate Course

Decision-Making for Generic Drug Entry & Branded Drug Lifecycle Management

  • When will key drug patents expire?
  • How can I find, evaluate, and plan for generic market entry opportunities?
  • How can I find proprietary out-of-court settlements and deal terms?
DrugPatentWatch - Make Better Decisions